Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Expert Opinion on Investigational Drugs
|
July 5, 2005
98th General Meeting of the American Society for Microbiology. May 17-21, 1998; Atlanta, GA
T J Dougherty, M J Pucci, D Beaulieu, et al.
Expert Opinion on Investigational Drugs
|
July 1, 1997
The 97th Annual Meeting of the American Society for Microbiology
M Frosco, M J Pucci, L Licata, et al.
Molecular and Cellular Biology
|
August 1, 1995
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain
A T Hoang, B Lutterbach, B C Lewis, et al.
Bioorganic & Medicinal Chemistry
|
July 29, 1998
Synthesis and inhibitory activity of novel tri- and tetracyclic quinolines against topoisomerases
Z Sui, J Altom, V N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
SAR studies of diaryltriazoles against bacterial two-component regulatory systems and their antibacterial activities
Z Sui, J Guan, D J Hlasta, et al.
The Journal of Biological Chemistry
|
October 13, 2001
A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation
J E Prescott, R C Osthus, L A Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 20, 2001
Amidino benzimidazole inhibitors of bacterial two-component systems
M A Weidner-Wells, K A Ohemeng, V N Nguyen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
September 3, 2015
Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial
E K Hutton, M E Hannah, S Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2000
Identification of CDK4 as a target of c-MYC
H Hermeking, C Rago, M Schuhmacher, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel
D J Hlasta, J P Demers, B D Foleno, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Expert Opinion on Investigational Drugs
|
July 5, 2005
98th General Meeting of the American Society for Microbiology. May 17-21, 1998; Atlanta, GA
T J Dougherty, M J Pucci, D Beaulieu, et al.
Expert Opinion on Investigational Drugs
|
July 1, 1997
The 97th Annual Meeting of the American Society for Microbiology
M Frosco, M J Pucci, L Licata, et al.
Molecular and Cellular Biology
|
August 1, 1995
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain
A T Hoang, B Lutterbach, B C Lewis, et al.
Bioorganic & Medicinal Chemistry
|
July 29, 1998
Synthesis and inhibitory activity of novel tri- and tetracyclic quinolines against topoisomerases
Z Sui, J Altom, V N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
SAR studies of diaryltriazoles against bacterial two-component regulatory systems and their antibacterial activities
Z Sui, J Guan, D J Hlasta, et al.
The Journal of Biological Chemistry
|
October 13, 2001
A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation
J E Prescott, R C Osthus, L A Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 20, 2001
Amidino benzimidazole inhibitors of bacterial two-component systems
M A Weidner-Wells, K A Ohemeng, V N Nguyen, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
September 3, 2015
Maternal outcomes at 3 months after planned caesarean section versus planned vaginal birth for twin pregnancies in the Twin Birth Study: a randomised controlled trial
E K Hutton, M E Hannah, S Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2000
Identification of CDK4 as a target of c-MYC
H Hermeking, C Rago, M Schuhmacher, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel
D J Hlasta, J P Demers, B D Foleno, et al.
Page
of 11